Literature DB >> 17941891

Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.

Yi-Na Liu1, Zhong-Min Zhou, Peng Chen.   

Abstract

1. The present study was conducted to investigate whether hydroxysafflor yellow A (HSYA) has a protective effect against heart injury after ischaemia-reperfusion and to determine the possible mechanism involved. 2. Hearts isolated from male Sprague-Dawley rats were perfused on a Langendorff apparatus and subjected to 30 min global ischaemia, followed by 120 min reperfusion. Infarct size and the level of lactate dehydrogenase (LDH) in the coronary effluent were determined. In mitochondria from isolated perfused hearts, Ca(2+)-induced swelling was observed. In isolated ventricular myocytes, depolarization of the mitochondrial membrane was determined by tetramethyl-rhodamine ethyl ester (TMRE) fluorescence. Furthermore, levels of phosphorylated endothelial nitric oxide synthase (eNOS) protein were measured by western blot. 3. Pretreatment with HSYA for 5 min before ischaemia reduced infarct size and the release of LDH. Administration of 20 micromol/L atractyloside, an opener of the mitochondrial permeability transition pore, and 10 micromol/L N(G)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NOS, attenuated the protective effects of HSYA. In mitochondria isolated from hearts pretreated with 0.1 mmol/L HSYA for 5 min, a significant inhibition of Ca(2+)-induced swelling was observed and this inhibition was attenuated by l-NAME. In isolated ventricular myocytes, pretreatment with HSYA prevented ischaemia-induced cell death and depolarization of the mitochondrial membrane, whereas atractyloside or l-NAME attenuated the effects of HSYA. Levels of phosphorylated eNOS protein were significantly enhanced in the HSYA-treated group. 4. The findings of the present study indicate that HSYA protects the myocardium against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. The effect of HSYA on mitochondrial permeability transition pore opening may be mediated through enhanced nitric oxide production by eNOS activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17941891     DOI: 10.1111/j.1440-1681.2007.04814.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  15 in total

1.  Hydroxysafflor yellow A (HYSA) inhibited the proliferation and differentiation of 3T3-L1 preadipocytes.

Authors:  Hui-Juan Zhu; Lin-Jie Wang; Xiang-Qing Wang; Hui Pan; Nai-Shi Li; Hong-Bo Yang; Ming Jin; Bao-Xia Zang; Feng-Ying Gong
Journal:  Cytotechnology       Date:  2015-03-07       Impact factor: 2.058

2.  Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.

Authors:  Wendan Yuan; Dongxia Yang; Xuhong Sun; Wei Liu; Liang Wang; Xiaoyan Li; Xuejing Man; Qiang Fu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  San-Huang-Xie-Xin-Tang protects cardiomyocytes against hypoxia/reoxygenation injury via inhibition of oxidative stress-induced apoptosis.

Authors:  Shu-Fen Liou; Jong-Hau Hsu; Jyh-Chong Liang; Hung-Jen Ke; Ing-Jun Chen; Jiunn-Ren Wu; Jwu-Lai Yeh
Journal:  J Nat Med       Date:  2011-10-08       Impact factor: 2.343

4.  AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats.

Authors:  Zhifeng Qi; Feng Yan; Wenjuan Shi; Chencheng Zhang; Wen Dong; Yongmei Zhao; Jiangang Shen; Xunming Ji; Ke Jian Liu; Yumin Luo
Journal:  Transl Stroke Res       Date:  2014-05-09       Impact factor: 6.829

5.  Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Authors:  Shujun Jiang; Zhen Shi; Changyong Li; Chunlei Ma; Xianyong Bai; Chaoyun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease.

Authors:  Zhengcan Zhou; Ting Shang; Xiurong Li; Hongyan Zhu; Yu-Bo Qi; Xin Zhao; Xi Chen; Zhe-Xin Shi; Guixiang Pan; Yue-Fei Wang; Guanwei Fan; Xiumei Gao; Yan Zhu; Yuxin Feng
Journal:  Front Physiol       Date:  2021-02-12       Impact factor: 4.566

7.  Enhanced effect and mechanism of water-in-oil microemulsion as an oral delivery system of hydroxysafflor yellow A.

Authors:  Jianping Qi; Jie Zhuang; Wei Wu; Yi Lu; Yunmei Song; Zhetao Zhang; Jia Jia; Qineng Ping
Journal:  Int J Nanomedicine       Date:  2011-05-10

8.  San-Huang-Xie-Xin-Tang Prevents Rat Hearts from Ischemia/Reperfusion-Induced Apoptosis through eNOS and MAPK Pathways.

Authors:  Shu-Fen Liou; Hung-Jen Ke; Jong-Hau Hsu; Jyh-Chong Liang; Hung-Hong Lin; Ing-Jun Chen; Jwu-Lai Yeh
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-14       Impact factor: 2.629

9.  Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies.

Authors:  Liang-Zhong Lv; Chen-Qi Tong; Qing Lv; Xin-Jiang Tang; Li-Ming Li; Qing-Xia Fang; Jia Yu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2012-07-30

10.  Serum Containing Tao-Hong-Si-Wu Decoction Induces Human Endothelial Cell VEGF Production via PI3K/Akt-eNOS Signaling.

Authors:  Dengke Yin; Zhuqing Liu; Daiyin Peng; Ye Yang; Xiangdong Gao; Fan Xu; Lan Han
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.